PSP Research’s Halozyme HALO Stock Holding History

PSP Research’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$548K	Sell	7,000 -1,026	-13%	-$70K	0.29%	13
2026 Q1	$519K	Hold	8,026	–	–	0.37%	11
2025 Q4	$540K	Buy	+8,026	New	+$540K	0.47%	22

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

PSP Research's HALO Position: Q2 2026 in Review

PSP Research reduced its Halozyme (HALO) stake by 13% in Q2 2026, selling an estimated $70K and leaving 7,000 shares worth $548K. The position accounts for 0.29% of the portfolio, ranked #13.

PSP Research first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 667 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

PSP Research held 7,000 shares of Halozyme worth $548K as of Q2 2026.
PSP Research sold 1,026 Halozyme shares in Q2 2026, an estimated $70K.
Halozyme made up 0.29% of PSP Research's portfolio in Q2 2026, its #13 holding.
PSP Research first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
667 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on PSP Research's 13F filing for Q2 2026, filed 9 Jul 2026.